标题
Cancer-induced muscle wasting: latest findings in prevention and treatment
作者
关键词
-
出版物
Therapeutic Advances in Medical Oncology
Volume 9, Issue 5, Pages 369-382
出版商
SAGE Publications
发表日期
2017-03-08
DOI
10.1177/1758834017698643
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CCP score and risk stratification for prostate cancer patients at biopsy.
- (2017) E. David Crawford et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia – can findings from animal models be translated to humans?
- (2016) Tara C. Mueller et al. BMC CANCER
- PTH/PTHrP Receptor Mediates Cachexia in Models of Kidney Failure and Cancer
- (2016) Serkan Kir et al. Cell Metabolism
- Protein anabolic resistance in cancer
- (2016) Mariëlle P.K.J. Engelen et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Exercise-induced skeletal muscle signaling pathways and human athletic performance
- (2016) Donny M. Camera et al. FREE RADICAL BIOLOGY AND MEDICINE
- The regulation of autophagy during exercise in skeletal muscle
- (2016) Anna Vainshtein et al. JOURNAL OF APPLIED PHYSIOLOGY
- Effects of skeletal muscle energy availability on protein turnover responses to exercise
- (2016) William J. Smiles et al. JOURNAL OF EXPERIMENTAL BIOLOGY
- Targeting cancer cachexia: we're on the way
- (2016) Maurizio Muscaritoli LANCET ONCOLOGY
- Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials
- (2016) Jennifer S Temel et al. LANCET ONCOLOGY
- Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia
- (2016) Tomoya Fukawa et al. NATURE MEDICINE
- Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later
- (2016) Aoife M. Ryan et al. PROCEEDINGS OF THE NUTRITION SOCIETY
- Experimental cancer cachexia: Evolving strategies for getting closer to the human scenario
- (2016) Fabio Penna et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)
- (2016) Jeffrey Crawford et al. Current Oncology Reports
- Beneficial bacteria inhibit cachexia
- (2016) Bernard J. Varian et al. Oncotarget
- Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial)
- (2016) Andrew J. Stewart Coats et al. Journal of Cachexia Sarcopenia and Muscle
- Aerobic Exercise and Pharmacological Treatments Counteract Cachexia by Modulating Autophagy in Colon Cancer
- (2016) Eva Pigna et al. Scientific Reports
- High anabolic potential of essential amino acid mixtures in advanced nonsmall cell lung cancer
- (2015) M. P. K. J. Engelen et al. ANNALS OF ONCOLOGY
- Mechanisms of anorexia–cachexia syndrome and rational for treatment with selective ghrelin receptor agonist
- (2015) Angela Esposito et al. CANCER TREATMENT REVIEWS
- Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs Survival
- (2015) Amelia J. Johnston et al. CELL
- Cachexia: A preventable comorbidity of cancer. A T.A.R.G.E.T. approach
- (2015) Maurizio Muscaritoli et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Muscle wasting
- (2015) Didier Attaix et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Novel investigational drugs mimicking exercise for the treatment of cachexia
- (2015) F. Penna et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Advances in pharmacologic strategies for cancer cachexia
- (2015) Clelia Madeddu et al. EXPERT OPINION ON PHARMACOTHERAPY
- Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC
- (2015) Hongjie Zhang et al. EXPERT OPINION ON PHARMACOTHERAPY
- Complete reversal of muscle wasting in experimental cancer cachexia: Additive effects of activin type II receptor inhibition and β-2 agonist
- (2015) Míriam Toledo et al. INTERNATIONAL JOURNAL OF CANCER
- Diagnostic Criteria for the Classification of Cancer-Associated Weight Loss
- (2015) Lisa Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Cachexia: Emerging pre-clinical evidence and the pathway forward to clinical trials
- (2015) Lisa Martin et al. JNCI-Journal of the National Cancer Institute
- Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia
- (2015) Yu-Chou Tseng et al. JNCI-Journal of the National Cancer Institute
- Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials
- (2015) José M Garcia et al. LANCET ONCOLOGY
- Muscle wasting in disease: molecular mechanisms and promising therapies
- (2015) Shenhav Cohen et al. NATURE REVIEWS DRUG DISCOVERY
- Eicosapentaenoic acid in cancer improves body composition and modulates metabolism
- (2015) Giulia Pappalardo et al. NUTRITION
- Preoperative Sarcopenia Negatively Impacts Postoperative Outcomes Following Major Hepatectomy with Extrahepatic Bile Duct Resection
- (2015) Hidehiko Otsuji et al. WORLD JOURNAL OF SURGERY
- Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations
- (2015) Fabrizio Pin et al. Oncotarget
- Effects of oral meal feeding on whole body protein breakdown and protein synthesis in cachectic pancreatic cancer patients
- (2015) David P.J. van Dijk et al. Journal of Cachexia Sarcopenia and Muscle
- Effect of the specific proteasome inhibitor bortezomib on cancer-related muscle wasting
- (2015) Fabio Penna et al. Journal of Cachexia Sarcopenia and Muscle
- Request for regulatory guidance for cancer cachexia intervention trials
- (2015) KCH Fearon et al. Journal of Cachexia Sarcopenia and Muscle
- A framework for prescription in exercise-oncology research
- (2015) John P. Sasso et al. Journal of Cachexia Sarcopenia and Muscle
- Cancer Cachexia: Emerging pre-clinical evidence and the pathway forward to clinical trials
- (2015) Lisa Martin et al. JNCI-Journal of the National Cancer Institute
- Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia
- (2015) Yu-Chou Tseng et al. JNCI-Journal of the National Cancer Institute
- The therapeutic potential of exercise to treat cachexia
- (2015) Fábio S. Lira et al. Current Opinion in Supportive and Palliative Care
- Satellite cells in human skeletal muscle plasticity
- (2015) Tim Snijders et al. Frontiers in Physiology
- Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle
- (2015) Francesca Pretto et al. Oncotarget
- A Switch from White to Brown Fat Increases Energy Expenditure in Cancer-Associated Cachexia
- (2014) Michele Petruzzelli et al. Cell Metabolism
- Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: Randomised trial
- (2014) Karla Sánchez-Lara et al. CLINICAL NUTRITION
- Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: From sarcopenic obesity to cachexia
- (2014) Gianni Biolo et al. CLINICAL NUTRITION
- Ghrelin
- (2014) Alessio Molfino et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Do patients with advanced cancer have any potential for protein anabolism in response to amino acid therapy?
- (2014) Stéphanie Chevalier et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Acylated and unacylated ghrelin administration to blunt muscle wasting
- (2014) Simone Reano et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Novel investigational biologics for the treatment of cancer cachexia
- (2014) Joseph D Ma et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Cancer cachexia: towards integrated therapeutic interventions
- (2014) Alessio Molfino et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Phase II drugs that are currently in development for the treatment of cachexia
- (2014) Anne-Marie C Dingemans et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Pharmacological Strategies in Lung Cancer-Induced Cachexia: Effects on Muscle Proteolysis, Autophagy, Structure, and Weakness
- (2014) Alba Chacon-Cabrera et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Efficacy of Methylprednisolone on Pain, Fatigue, and Appetite Loss in Patients With Advanced Cancer Using Opioids: A Randomized, Placebo-Controlled, Double-Blind Trial
- (2014) Ørnulf Paulsen et al. JOURNAL OF CLINICAL ONCOLOGY
- MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study
- (2014) David S Hong et al. LANCET ONCOLOGY
- Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia
- (2014) Serkan Kir et al. NATURE
- Voluntary Exercise Prevents Cisplatin-Induced Muscle Wasting during Chemotherapy in Mice
- (2014) Pernille Hojman et al. PLoS One
- Distinct Behaviour of Sorafenib in Experimental Cachexia-Inducing Tumours: The Role of STAT3
- (2014) Míriam Toledo et al. PLoS One
- Phase I/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy
- (2014) C. A. Greig et al. SUPPORTIVE CARE IN CANCER
- Formoterol in the treatment of experimental cancer cachexia: effects on heart function
- (2014) Míriam Toledo et al. Journal of Cachexia Sarcopenia and Muscle
- Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?
- (2013) Carla M Prado et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Beta-hydroxy-beta-methylbutyrate supplementation in health and disease: a systematic review of randomized trials
- (2013) Alessio Molfino et al. AMINO ACIDS
- Physical activity and physical fitness in lymphoma patients before, during, and after chemotherapy: a prospective longitudinal study
- (2013) Nele Vermaete et al. ANNALS OF HEMATOLOGY
- Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma
- (2013) N. Harimoto et al. BRITISH JOURNAL OF SURGERY
- A new look at an old drug for the treatment of cancer cachexia: Megestrol acetate
- (2013) Josep M. Argilés et al. CLINICAL NUTRITION
- Effect of physical exercise on muscle mass and strength in cancer patients during treatment—A systematic review
- (2013) G.B. Stene et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Changes in insulin sensitivity in response to different modalities of exercise: a review of the evidence
- (2013) S. Mann et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Muscle wasting in cancer
- (2013) N. Johns et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- MG132-mediated inhibition of the ubiquitin–proteasome pathway ameliorates cancer cachexia
- (2013) Liuping Zhang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Reduction of Cancer-Related Fatigue With Dexamethasone: A Double-Blind, Randomized, Placebo-Controlled Trial in Patients With Advanced Cancer
- (2013) Sriram Yennurajalingam et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
- (2013) Lisa Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- Skeletal muscle, autophagy, and physical activity: the ménage à trois of metabolic regulation in health and disease
- (2013) Anna Vainshtein et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial
- (2013) Adrian S Dobs et al. LANCET ONCOLOGY
- Comparison of the anticatabolic effects of leucine and Ca-β-hydroxy-β-methylbutyrate in experimental models of cancer cachexia
- (2013) Kamran A. Mirza et al. NUTRITION
- Relationship between muscle mass and muscle strength, and the impact of comorbidities: a population-based, cross-sectional study of older adults in the United States
- (2013) Lei Chen et al. BMC Geriatrics
- Abstracts of the 7th Cachexia Conference, Kobe/Osaka, Japan, December 9-11, 2013
- (2013) Journal of Cachexia Sarcopenia and Muscle
- Non-steroidal anti-inflammatory treatment in cancer cachexia: A systematic literature review
- (2012) Tora S. Solheim et al. ACTA ONCOLOGICA
- JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia
- (2012) Andrea Bonetto et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Differential Effects of Exercise on Cancer-Related Fatigue During and Following Treatment
- (2012) Timothy W. Puetz et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma
- (2012) C M M Prado et al. BRITISH JOURNAL OF CANCER
- Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery
- (2012) J R Lieffers et al. BRITISH JOURNAL OF CANCER
- Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
- (2012) Kenneth C.H. Fearon et al. Cell Metabolism
- l-Carnitine: An adequate supplement for a multi-targeted anti-wasting therapy in cancer
- (2012) Sílvia Busquets et al. CLINICAL NUTRITION
- Normal protein anabolic response to hyperaminoacidemia in insulin-resistant patients with lung cancer cachexia
- (2012) Aaron Winter et al. CLINICAL NUTRITION
- Is the intravenous supplementation of amino acid to cancer patients adequate? A critical appraisal of literature
- (2012) Federico Bozzetti et al. CLINICAL NUTRITION
- Resistance exercise modulates lipid plasma profile and cytokine content in the adipose tissue of tumour-bearing rats
- (2012) F.F. Donatto et al. CYTOKINE
- The Role of Thalidomide and Placebo for the Treatment of Cancer-Related Anorexia-Cachexia Symptoms: Results of a Double-Blind Placebo-Controlled Randomized Study
- (2012) Sriram Yennurajalingam et al. JOURNAL OF PALLIATIVE MEDICINE
- Understanding the mechanisms and treatment options in cancer cachexia
- (2012) Kenneth Fearon et al. Nature Reviews Clinical Oncology
- JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
- (2012) Claire Harrison et al. NEW ENGLAND JOURNAL OF MEDICINE
- L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial
- (2012) Matthias Kraft et al. Nutrition Journal
- Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study
- (2012) José M. Garcia et al. SUPPORTIVE CARE IN CANCER
- Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study
- (2012) Adriana Villaseñor et al. Journal of Cancer Survivorship
- Are there any benefits of exercise training in cancer cachexia?
- (2012) Josep M. Argilés et al. Journal of Cachexia Sarcopenia and Muscle
- Cancer cachexia prevention via physical exercise: molecular mechanisms
- (2012) Douglas W. Gould et al. Journal of Cachexia Sarcopenia and Muscle
- Sarcopenia, Dynapenia, and the Impact of Advancing Age on Human Skeletal Muscle Size and Strength; a Quantitative Review
- (2012) W. Kyle Mitchell et al. Frontiers in Physiology
- l-Carnitine induces recovery of liver lipid metabolism in cancer cachexia
- (2011) Renata Silvério et al. AMINO ACIDS
- Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial
- (2011) T. D. Brisbois et al. ANNALS OF ONCOLOGY
- Changes in Myostatin Signaling in Non-Weight-Losing Cancer Patients
- (2011) Zaira Aversa et al. ANNALS OF SURGICAL ONCOLOGY
- Chemotherapy-Induced Weakness and Fatigue in Skeletal Muscle: The Role of Oxidative Stress
- (2011) Laura A.A. Gilliam et al. ANTIOXIDANTS & REDOX SIGNALING
- Carnitine Administration Reduces Cytokine Levels, Improves Food Intake, and Ameliorates Body Composition in Tumor-Bearing Rats
- (2011) Alessandro Laviano et al. CANCER INVESTIGATION
- Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical food
- (2011) Nicolaas E.P. Deutz et al. CLINICAL NUTRITION
- Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome
- (2011) Clelia Madeddu et al. CLINICAL NUTRITION
- Beyond anorexia -cachexia. Nutrition and modulation of cancer patients' metabolism: Supplementary, complementary or alternative anti-neoplastic therapy?
- (2011) Alessandro Laviano et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A Phase II Dose Titration Study of Thalidomide for Cancer-Associated Anorexia
- (2011) Mellar Davis et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- Pre-cachexia in patients with stages I–III non-small cell lung cancer: Systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system
- (2011) C.M. Op den Kamp et al. LUNG CANCER
- Formoterol and cancer muscle wasting in rats: Effects on muscle force and total physical activity
- (2011) SÍLVIA BUSQUETS et al. Experimental and Therapeutic Medicine
- Combined approach to counteract experimental cancer cachexia: eicosapentaenoic acid and training exercise
- (2011) Fabio Penna et al. Journal of Cachexia Sarcopenia and Muscle
- The effect of exercise on IL-6-induced cachexia in theApcMin/+mouse
- (2011) Melissa J. Puppa et al. Journal of Cachexia Sarcopenia and Muscle
- Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
- (2010) Xiaolan Zhou et al. CELL
- Resistance exercise and appropriate nutrition to counteract muscle wasting and promote muscle hypertrophy
- (2010) Elisa I Glover et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Corticosteroids and muscle wasting: role of transcription factors, nuclear cofactors, and hyperacetylation
- (2010) Per-Olof Hasselgren et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- The “parallel pathway”: a novel nutritional and metabolic approach to cancer patients
- (2010) Maurizio Muscaritoli et al. Internal and Emergency Medicine
- Association of Skeletal Muscle Wasting With Treatment With Sorafenib in Patients With Advanced Renal Cell Carcinoma: Results From a Placebo-Controlled Study
- (2010) Sami Antoun et al. JOURNAL OF CLINICAL ONCOLOGY
- Muscle Wasting and Impaired Myogenesis in Tumor Bearing Mice Are Prevented by ERK Inhibition
- (2010) Fabio Penna et al. PLoS One
- An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis
- (2010) Rebecca M. Speck et al. Journal of Cancer Survivorship
- Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia
- (2009) Margaret E. Benny Klimek et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer
- (2009) B. H.L. Tan et al. CLINICAL CANCER RESEARCH
- Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
- (2009) C. M.M. Prado et al. CLINICAL CANCER RESEARCH
- Deacetylase Inhibitors Modulate the Myostatin/Follistatin Axis without Improving Cachexia in Tumor-Bearing Mice
- (2009) A. Bonetto et al. CURRENT CANCER DRUG TARGETS
- Muscle myostatin signalling is enhanced in experimental cancer cachexia
- (2008) P. Costelli et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
- (2008) Carla MM Prado et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started